Molecular mechanisms of new immunosuppressants

Clinical Transplantation

Volumn 10, Issue 1 II, 1996, Pages 118-123

  Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cyclosporine; Deoxyspergualin; Mizoribine; Mycophenolate mofetil; Mycophenolic acid; Rapamycin; Tacrolimus

Indexed keywords

15 DEOXYSPERGUALIN; BREQUINAR; CALCINEURIN; CYCLOPHILIN; CYCLOSPORIN; GUANINE NUCLEOTIDE; IMMUNOSUPPRESSIVE AGENT; INOSINATE DEHYDROGENASE; LEFLUNOMIDE; MIZORIBINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

B LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; CONFERENCE PAPER; DRUG BINDING; DRUG HYDROLYSIS; DRUG MECHANISM; ENZYME INHIBITION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; PURINE SYNTHESIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

AMINO ACID ISOMERASES; B-LYMPHOCYTES; BIPHENYL COMPOUNDS; CALCINEURIN; CALMODULIN-BINDING PROTEINS; CARRIER PROTEINS; CYCLOSPORINE; ENZYME INHIBITORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; ISOXAZOLES; MYCOPHENOLIC ACID; OXIDOREDUCTASES; PEPTIDYLPROLYL ISOMERASE; PHOSPHOPROTEIN PHOSPHATASE; POLYENES; PURINES; PYRIMIDINES; RECEPTORS, CYTOKINE; RIBONUCLEOSIDES; SIGNAL TRANSDUCTION; SIROLIMUS; T-LYMPHOCYTES; TACROLIMUS;

EID: 0029870723     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. ALLISON AC, EUGUI EM. Mycophenolate mofetil (RS-61443): mode of action and effects on graft rejection. In: THOMPSON AW. STARZL TF, eds. Immunosuppressive Drugs, Developments in Anti-Rejection Therapy. New York: Edward Arnold, 1994: 141.
2. PLATZ KP, SOLLINGER HW, HULLET DA. ECKHOEF DE. EUGUI EM, ALLISON AC. RS-61443 - A new. potent immunosuppressive agent. Transplantation 1991: 51: 27.
3. ULLMAN B. Characterization of mutant murine lymphoma cells with altered inosinate dehydrogenase activities. J Biol Chem 1983: 258: 523.
4. LUCAS DL, WEBSTER HK, WRIGHT DG. Purine metabolism in myeloid precursor cells during maturation. J Clin Invest 1983: 72: 1889.
5. SOKOLOSKI JA, BLAIR OC, SARTORELLI AC. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5́-phosphate dehydrogenase Cancer Res 1986: 46: 2314.
6. ALLISON AC, HOVI T, WATTS RWE, WEBSTER ADB. Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation. Lancet 1975: 2: 1179.
7. MORRIS RE. New small molecule immunosuppressants for transplantation: review of essential concepts. J Heart Lung Transplant 1993: 12: S275.
8. ALLISON AC, EUGUI EM. Inhibitors of de novo purine and pyrimidine synthesis as immunosuppressive drugs. Transplant Proc 1993: 25 (suppl 2): 8.
9. DAYTON JS, TURKA LA, THOMPSON CB, MITCHELL BS. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism. Mol Pharmacol 1992: 41: 671.
10. TURKA LA, DAYTON J, SINCLAIR G, THOMPSON CB, MITCHELL BS. Guanine ribonucleotide depletion inhibits T cell activation. J Clin Invest 1991: 87: 940.
11. GRYPOTIC C-G, OHLMAN S, GANNEDAHL G, ERICZON B-G. New immunosuppressive drugs in transplantation. Transplant Proc 1993: 25: 2681.
12. SWEENEY MJ, HOFFMAN DH, ESTERMAN MA. Metabolism and biochemistry of mycophenolic acid. Cancer Res 1972: 32: 1803.
13. MORRIS PJ. Cyclosporine, FK506, and other drugs in organ transplantation. Curr Opin Immunol 1991: 3: 748.
14. ALLISON AC, EUGUI EM. The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol 1993: 14. 353.
15. FRANKLIN TJ, COOK JM. The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J 1969: 113: 515.
16. HALLORAN PF. Aspects of allograft rejection, IV: evaluation of new pharmacologic agents for prevention of allograft rejection. Transplant Rev 1995: 9: 138.
17. ALLISON AC, EUGUI EM. Immunosuppressive and long-acting anti-inflammatory activity of mycophenolic acid and derivative, RS-61443. Br J Rheum 1991: 30 (suppl 2): 57.
18. THOMSON AW. STARZL TE. New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol Rev 1993: 136: 71.
19. DEIERHOI MH, SOLLINGER HW, DIETHELM AG, BELZER FO, KAUFFMAN RS. One-year follow-up results of a phase I trial of mycophenolate mofetil (RS61443) in cadaveric renal transplantation. Transplant Proc 1993: 25: 693.
20. KAHAN BD. Cyclosporine. N Engl J Med 1989: 321: 1725.
21. REED JC, PRYSTOWSKY MB, NOWELL PC. Regulation of gene expression m lectin-stimulated or lymphocyte-stimulated T lymphocytes. Transplantation 1988: 46: 85S.
22. BUMGARDNER GL, ROBERTS JR New immunosuppressive agents. Adv Liver Transplant 1993: 22: 421.
23. BATIUK TD, PAZDERKA J, HALLORAN PE Calcineurin activity is only partially inhibited in leukocytes of cyclosporine treated patients. Transplantation 1995: 59: 1400.
24. COLLIER STJ. Immunosuppresive drugs. Curr Opin Immunol 1990: 2: 854.
25. SIEKERA JJ, WIEDERECHT G, GRENLICH G, et al. The cytosolic-binding protein for the immunosuppressant FK506 is both a ubiquitous and highly conserved peptidyl-prolyl cis-trans-isomerase. J Biol Chem 1990: 265: 2101.
26. GRIFFITH JP, KIM JL, KIM EE. SINTCHAK MD, THOMSON JA. FITZGIBBON MJ, FLEMING MA, CARON PR, HSIAO K, NAVIA MAI: X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell 1995: 82: 507.
27. SUPERDOCK KR, HELDERMAN JH. Immunosuppressive drugs and their effects. Semin Respir Infect 1993: 8: 152.
28. LIU J, FARMER JD JR, LANE WS, et al. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991: 66: 807.
29. BIERER BE. Advances in therapeutic immunosuppression: biology, molecular actions, and clinical implications. Curr Opin Hematol 1993: 149.
30. THOMSON AW. The spectrum of action of new immunosuppressive drugs. Clin Exp Immunol 1992: 89: 170.
31. Nature (London) 1995: In press.
32. CHUNG J, KUO CJ, CRABTREE GR, et al. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases. Cell 1992: 69: 1227.
33. Kuo CJ, CHUNG J, FIORENTINO DF et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature (London) 1992: 358: 70.
34. DUMONT FJ, ALTMEYER A, KASTNER C, et al. Relationship between multiple biologic effects of rapamycin and the inhibition of p70S6 protein kinase activity. J Immunol 1994: 152: 992.
35. SABATINI DM. ERDJUMENT-BROMAGE H, LUI M, et al. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 1994: 78: 35.
36. BROWNE EJ, ALBERS MW, SHIN TB, et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (London) 1994: 369: 756.
37. ZHENG XF, et al. TOR kinase domains are required for two distinct functions. only one of which is inhibited by rapamycin. Cell 1995: 82: 121.
38. SIMMONS RL, WANG SC New horizons in immunosuppression. Transplant Proc 1991: 23: 2152.
39. MUNN SR. Renal transplantation: is the impact of new molecules acting on the immune system already clinically measurable? J Nephrol 1994: 6: 6.
40. TEPPER MA, NADLER SG, MAZZUCCO C, et al. Mechanism of action of 15 eoxyspergualin, a novel immunosuppressive drug. Ann NY Acad Sci 685: 136.
41. NADLER SG, TEPPER MA, SCHACTER B, MAZZUCCO CE. Interaction of the immunosuppressant deoxyspergualin with a member of the hsp70 family of heat shock proteins. Science 258: 484.
42. DE NAGEL DC, PIERCE SK. A case for chaperones in antigen processing. Immunol Today 1992: 13: 86.
43. HOEGER PH. TEPPER MA, FAITH A. et al. The immunosuppressant deoxyspergualin (DSG) inhibits antigen processing in monocytes. J Immunol 1994: 153: 3908.
44. AUPHAN N. DI DONATO JA, ROSETTE C, HELMBERG A, KARIN M. Immunosuppression by glucocorticoids: inhibition of NK-κB activity through induction of IκB synthesis. Science 1995: 270: 286.
45. SCHEINMAN RI. COGSWELL PC. LOFQUIST AK, BALDWIN AS Jr. Role of transcriptional activation of TκBα in mediation of immunosuppression by glucocorticoids. Science 1995: 270: 283.